-The Times of India NEW DELHI: In a move that could significantly bring down prices of expensive medicines, a high-level committee has recommended capping of trade margins for costly drugs at 35% of MRP (maximum retail price). The recommendations - part of a report submitted by an inter-ministerial committee - have been put in the public domain by the Department of Pharmaceuticals, inviting comments on the suggestions. The committee was set up...
More »SEARCH RESULT
Total Matching Records found : 75
Govt to sell 439 key drugs at low prices -Sushmi Dey
-The Times of India NEW DELHI: The government is set to expand the coverage of its Jan Aushadhi scheme. It will offer 439 life-saving medicines, including cancer and cardiovascular drugs, as well as 250 medical devices like stents and implants at 40-50% discounted prices. The Department of Pharmaceuticals plans to open 300 Jan Aushadhi stores across the country by March and another 3,000 by 2017. Presently, only 45 medicines are available in...
More »Pharma companies may be fined for freebies to doctors -Sushmi Dey
-The Times of India NEW DELHI: Pharma companies may have to cough up huge penalties for unethical and illegal practices like offering freebies, gifts and foreign trips to doctors for pushing the sales of their products. The government is set to make mandatory the uniform code of conduct for pharmaceutical marketing practices, which have so far been voluntary. The Department of Pharmaceuticals (DoP) is working on a draft which will curb unethical...
More »Soon, cancer medicines, stents to be cheaper -Sushmi Dey
-The Times of India NEW DELHI: Cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. . The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on...
More »Health ministry against task force proposal to hike prices of vital drugs -Sushmi Dey
-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...
More »
